Advertisement

Topics

BioFortis, Inc. Adds Mark Engelhart to Senior Executive Team

09:35 EDT 6 Sep 2017 | PR Web

BioFortis, Inc. announced today that Mark Engelhart has joined its senior leadership team as the company’s Chief Commercial Officer, responsible for its sales and marketing functions.

Columbia, MD (PRWEB) September 06, 2017

BioFortis, Inc. announced today that Mark Engelhart has joined its senior leadership team as the company’s Chief Commercial Officer, responsible for its sales and marketing functions.

Mr. Engelhart has over 25 years of experience in the Pharmaceutical and Contract Research Organization (CRO) industries, most recently serving as Chief Commercial Officer of ACM Global Laboratories.

“Mark brings a wealth of experience and knowledge of the biopharma, central lab, and CRO markets to his new role with BioFortis. His addition to our team will help us continue the strong growth we have experienced in providing complete biospecimen lifecycle management solutions, which has become a critical need for modern biomarker-driven clinical trials," said Jian Wang, BioFortis’ Chief Executive Officer. "His knowledge of the requirements and pressures our clients face, and his longstanding commitment to providing excellent service to clients, will help our team further strengthen our industry leading position.”

About BioFortis
BioFortis is a leading provider of clinical development technology solutions which empower complete biospecimen lifecycle management. Its flagship product, Labmatrix, provides clinical trial sample & consent tracking, study subject & biobank management, and sophisticated data management capabilities leveraging the full potential of patient and sample-related information. With enterprise-level capabilities for integrating eClinical and bioresearch data collections in a harmonized, tightly-linked, and regulatory-compliant manner, Labmatrix empowers its users to easily ask sophisticated ad hoc questions and generate insights, reports, and dashboard visualizations. For more information, contact us at info(at)biofortis(dot)com, visit http://www.biofortis.com, or follow BioFortis on LinkedIn.

For the original version on PRWeb visit: http://www.prweb.com/releases/2017/09/prweb14662875.htm

NEXT ARTICLE

More From BioPortfolio on "BioFortis, Inc. Adds Mark Engelhart to Senior Executive Team"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...